Best Practices for Communicating Benefit, Risk, and Uncertainty for Medical Devices

Appropriate communication of benefits, risks, and uncertainty is essential at every stage of the medical device life cycle. Products can be designed, and studies conducted, based on the risk, benefit, and uncertainty preferences of the target patient population. During review, approval, and subsequent use of a device, manufacturers and regulators have an obligation to ensure that benefits, risks, and uncertainty associated with the device are communicated in an understandable way. Similarly, in the clinical setting, patient-centered care requires effective communication of benefits, risks, and uncertainty between patients and providers. There is increasing awareness surrounding the importance of patient engagement during the treatment decision making
process, as well as across the medical technology product development cycle by industry
and regulators.

The intent of this report, developed by the Science of Patient Input Communication Working Group of the Medical Device Innovation Consortium, is to familiarize all medical device stakeholders with evidence-based practices for communicating the benefits, risks, and uncertainty of medical technology to patients and providers.

An informational webinar was held on this report on October 2, 2020. View a recording of the webinar here.

More Like This

Top 10 Strategies: Unlocking US Market Access and Reimbursement for Emerging Medical Technologies

Patient Engagement in Clinical Trials: Patient, Industry, and Clinical Investigator Perspectives

Maximizing Patient Input in the Design and Development of Medical Device Clinical Trials